U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110571) titled 'A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer' on July 31.
Brief Summary: This is a multi-cohort, multi-center Phase II clinical study exploring the efficacy of treatment with either Adebrelimab plus SHR-A1811/SHR-A1904 and chemotherapy, or Adebrelimab plus SHR-8068 in patients with gastric or gastroesophageal junction (GEJ) cancer. The study also evaluates the safety and tolerability of these combination regimens.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Gastric Cancer
Gastroesophageal-junction Cancer
Intervention:
DRUG: Adebrelimab...